ImmunityBio (IBRX) Enterprise Value: 11.70B

ImmunityBio, Inc. (IBRX)

10.28 +1.00 (+10.83%) USD | NASDAQ | Oct 02, 16:00

10.30 +0.02 (+0.15%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2015. Start Trial.

Date	Value
October 02, 2026	11.70B
October 01, 2026	10.65B
September 30, 2026	10.81B
September 29, 2026	10.17B
September 28, 2026	9.845B
September 25, 2026	9.761B
September 24, 2026	9.972B
September 23, 2026	9.961B
September 22, 2026	10.66B
September 21, 2026	9.772B
September 18, 2026	9.803B
September 17, 2026	9.782B
September 16, 2026	9.203B
September 15, 2026	9.445B
September 14, 2026	9.687B
September 11, 2026	9.203B
September 10, 2026	9.003B
September 09, 2026	9.361B
September 08, 2026	9.603B
September 04, 2026	9.382B
September 03, 2026	9.498B
September 02, 2026	9.245B
September 01, 2026	9.161B
August 31, 2026	9.245B
August 28, 2026	9.350B

Date	Value
August 27, 2026	9.719B
August 26, 2026	9.561B
August 25, 2026	9.498B
August 24, 2026	8.855B
August 21, 2026	9.076B
August 20, 2026	9.129B
August 19, 2026	9.435B
August 18, 2026	9.003B
August 17, 2026	9.213B
August 14, 2026	8.845B
August 13, 2026	8.929B
August 12, 2026	9.024B
August 11, 2026	8.876B
August 10, 2026	8.761B
August 07, 2026	8.919B
August 06, 2026	8.581B
August 05, 2026	8.508B
August 04, 2026	8.192B
August 03, 2026	8.402B
July 31, 2026	8.423B
July 30, 2026	8.718B
July 29, 2026	8.065B
July 28, 2026	8.213B
July 27, 2026	8.234B
July 24, 2026	8.350B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks